Menu
Log in
Forgot password
Log in
Forgot password

PARTNERS

CAMO PARTNERS

CURRENT ONCOLOGY

Current Oncology (ISSN 1718-7729) is an international, peer-reviewed, open access journal published online by MDPI (from Volume 28 Issue 1-2021). Established in 1994, the journal represents a multidisciplinary medium for clinical oncologists to report and review progress in the management of this disease. Dr. Shahid Ahmed from the University of Saskatchewan has served as Editor-in-Chief of Current Oncology since June 2023. The journal is supported by an international editorial board consisting of a distinguished team of cancer researchers from major institutes from Canada and around the world (http://www.mdpi.com/journal/curroncol/editors). Articles published in the journal typically contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology is indexed by important databases, including SCIE, PubMed, MEDLINE, and Scopus. Current Oncology received an increased Impact Factor for 2023 of 2.8, following an increased CiteScore of 3.3. Current Oncology now ranks in Q2 in the “Oncology” category (157/322) which represents our ranking relative to other journals in the same field. More information about the journal can be accessed at: http://www.mdpi.com/journal/curroncol.



CAMO members enjoy author fee discounts with Current Oncology. Please contact the CAMO Office for the discount code or email Karen (karen.irwin@mdpi.com) when submitting your paper, to let her know to apply the discount.



NOTE:  When you apply for research funding, please inquire whether your granting agency allows the costs of open access publishing, such as Article Processing Charges, to be included in the grant budget.  More and more, granting agencies are encouraging or even requiring that all papers resulting from funded research must be published in Open Access journals.

More information about the journal can be accessed here.


BREAST CANCER CANADA (BCC)


Breast Cancer Canada (BCC) invests donations into life-saving research that directly impacts Canadian patients. That means better answers, bigger breakthroughs – and more personalized treatment for every breast cancer diagnosis. The more we know, the sooner we can end it.

For over 3 decades, BCC has supported Canadian research in breast cancer and is excited to collaborate with Canadian Association of Medical Oncologists (CAMO) in a research initiative aimed at supporting the next generation of medical oncology fellows specializing in breast cancer. The BCC-CAMO/ACOM partnership is dedicated to fostering the development of early-career oncologists with a lasting focus on breast cancer research, supporting advancements in Canada within the next 3-5 years.

The Breast Cancer Canada/Canadian Association of Medical Oncologists Clinician-Scientist Fellowship in Breast Cancer grant will be funded by BCC and managed by CAMO Fellowship Committee with 2 goals for BCC:

1. To generate a positive impact on Canadian breast cancer patients to improve recurrence and survival rates, treatment options and the lived experience of a breast cancer diagnosis.

2. To support ongoing Canadian academic leadership in the field of breast cancer medical oncology.

For more information on Breast Cancer Canada and the Canadian research we fund, please visit BCC's website.



Canadian Association of Medical Oncologists
PO Box 35033 RPO Westgate

Ottawa, ON K1Z 1A2

Phone: 613.415.6033
Email: info@camo-acom.ca

Powered by Wild Apricot Membership Software